Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Loew

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMC Biotechnology|January 23, 2013
Graded or threshold response of the tet-controlled gene expression: all depends on the concentration of the transactivatorNiels Heinz, Katharina Hennig, Rainer Loew
BMC Biotechnology|November 26, 2010
Improved Tet-responsive promoters with minimized background expressionRainer Loew, Niels Heinz, Mathias Hampf, et al.
Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research|July 1, 2009
Retroviral vectors containing Tet-controlled bidirectional transcription units for simultaneous regulation of two gene activitiesRainer Loew, Elisa Vigna, Dirk Lindemann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2007
Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectorsAxel Schambach, Melanie Galla, Tobias Maetzig, et al.
Human Gene Therapy|September 10, 2010
Retroviral and transposon-based tet-regulated all-in-one vectors with reduced background expression and improved dynamic rangeNiels Heinz, Axel Schambach, Melanie Galla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2002
Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectorsElisa Vigna, Simona Cavalieri, Laurie Ailles, et al.
International Journal of Cancer|March 25, 2010
Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosisDana Briesemeister, Daniel Sommermeyer, Christoph Loddenkemper, et al.
European Journal of Immunology|October 12, 2013
TCR-engineered T cells: a model of inducible TCR expression to dissect the interrelationship between two TCRsSimone Reuß, Zsolt Sebestyén, Niels Heinz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker geneRainer Loew, Nathalie Selevsek, Boris Fehse, et al.
Human Gene Therapy. Clinical Development|November 11, 2014
HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNAKatharina Hennig, Lars Raasch, Carolin Kolbe, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Biotechnology|January 23, 2013
Graded or threshold response of the tet-controlled gene expression: all depends on the concentration of the transactivatorNiels Heinz, Katharina Hennig, Rainer Loew
BMC Biotechnology|November 26, 2010
Improved Tet-responsive promoters with minimized background expressionRainer Loew, Niels Heinz, Mathias Hampf, et al.
Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research|July 1, 2009
Retroviral vectors containing Tet-controlled bidirectional transcription units for simultaneous regulation of two gene activitiesRainer Loew, Elisa Vigna, Dirk Lindemann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2007
Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectorsAxel Schambach, Melanie Galla, Tobias Maetzig, et al.
Human Gene Therapy|September 10, 2010
Retroviral and transposon-based tet-regulated all-in-one vectors with reduced background expression and improved dynamic rangeNiels Heinz, Axel Schambach, Melanie Galla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2002
Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectorsElisa Vigna, Simona Cavalieri, Laurie Ailles, et al.
International Journal of Cancer|March 25, 2010
Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosisDana Briesemeister, Daniel Sommermeyer, Christoph Loddenkemper, et al.
European Journal of Immunology|October 12, 2013
TCR-engineered T cells: a model of inducible TCR expression to dissect the interrelationship between two TCRsSimone Reuß, Zsolt Sebestyén, Niels Heinz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker geneRainer Loew, Nathalie Selevsek, Boris Fehse, et al.
Human Gene Therapy. Clinical Development|November 11, 2014
HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNAKatharina Hennig, Lars Raasch, Carolin Kolbe, et al.
Pageof 2